What does availability really mean in healthcare? For providers, it’s not just about whether a product exists somewhere in the supply chain. It’s about whether they can access the right therapy, at the right time, with the fewest barriers possible. Learn more about how Cencora is examining the challenges that are affecting product accessibility and leveraging smarter demand planning to help: https://bit.ly/4gz7iaa
About us
Cencora, a company building on the legacy of AmerisourceBergen, is a leading global pharmaceutical solutions organization centered on improving the lives of people and animals around the world. We connect manufacturers, providers, and patients to ensure that anyone can get the therapies they need, where and when they need them. We also help our partners bring their innovations to patients more efficiently to accelerate positive outcomes. Becoming Cencora has allowed us to combine all the companies and services of AmerisourceBergen. Now, as a unified and internationally inclusive brand, we’re continuing to invest in and focus on our core pharmaceutical distribution business, while also growing our platform of pharma and biopharma services to support pharmaceutical innovation and access. Our 51,000 worldwide team members are shaping the future of healthcare through the power of our purpose: We are united in our responsibility to create healthier futures. AmerisourceBergen, now Cencora, is ranked #10 on the Fortune 500 and #24 on the Global Fortune 500 with more than $290 billion in annual revenue.
- Website
-
https://www.cencora.com/
External link for Cencora
- Industry
- Hospitals and Health Care
- Company size
- 10,001+ employees
- Type
- Public Company
- Specialties
- pharmaceutical distribution, supply chain management, pharmaceutical service, product commercialization, healthcare logistics, provider efficiency technologies, consulting, and business coaching
Employees at Cencora
Updates
-
In conversation with Dr. Shushan Hovsepyan on OncoDaily TV, Tommy Bramley, SVP of Global Consulting at Cencora discusses how launching innovative oncology therapies has evolved in today's healthcare environment. From leveraging real-world evidence to overcoming logistical barriers, Tommy shares insights from Cencora's experience supporting more than 1,500 drug launches and more. Watch now: https://bit.ly/4xoM6uS
-
-
Cencora reposted this
For cell and gene therapies (CGTs), pharmacovigilance (PV) can’t be treated as an afterthought. With unique safety considerations and long-term follow-up requirements, PV needs to be integrated early—helping organizations anticipate risks, generate meaningful safety insights and support better outcomes throughout the product lifecycle. In our latest article, Louis Cicchini, PhD, PhD, Senior Director of Scientific Affairs & Strategic Partnerships for CGT, and STEPHEN SUN, MD, VP of Pharmacovigilance, explore why PV is becoming a strategic driver for CGT success. Read the full article: https://lnkd.in/ezCymaFn
-
-
In FY25, Cencora picked, packed, and shipped over one billion medications for patients worldwide. Inside the FY25 Corporate Responsibility Report, explore how Cencora is delivering healthier futures at this global scale by focusing on our purpose-driven team members, resilient and sustainable operations, and healthy communities. Access the report: https://bit.ly/4brRjbu
-
-
“Cencora is dedicated to building a stronger, more resilient healthcare supply chain across the globe. As a part of this ongoing work, we respond when communities need it most. Following the devastating earthquakes in Colombia, the Cencora Impact Foundation is supporting Americares to provide healthcare workers and first responders with the necessary supplies to treat survivors including clean water, hygiene kits, and relief supplies in the affected communities.” - Ken Hardy, SVP - US Supply Chain Operations for Cencora and President of the Cencora Impact Foundation The Cencora Impact Foundation also proactively supports Americares Rapid Impact and Support for Emergencies (RISE) Program, for immediate disaster response, long-term recovery, and emergency preparedness worldwide. Learn more about our emergency response efforts: https://bit.ly/43tuBNd
-
-
The world of medicine isn’t getting any simpler. Scientific breakthroughs will continue, and technology will keep advancing. Cencora’s approach, grounded in ongoing investment, operational discipline, and a commitment to innovation, is designed to meet that reality head-on. The strategies we’re implementing today are focused on future-proofing supply chain operations so patients can depend on uninterrupted access to the medications they need. Learn more about how Cencora is building a more resilient pharmaceutical distribution ecosystem: https://bit.ly/4g88jpB
-
Cencora reposted this
As the global market remains complex, with no signs of simplification, organisations are relying on 3PL companies to ensure streamlined operations. “We see pharma companies homing in on what they do best – developing and commercialising their products; and 3PL providers serve as trusted partners to ensure that the activities outside of this are executed perfectly.” explains Alina Chesnokova, Vice President of Global 3PL Commercialisation at Cencora Read the full article in Supply Chain Digital: https://lnkd.in/dTHrGJVZ
-
-
According to the Business Continuity Institute, nearly 80% of organizations experienced at least one supply chain disruption over a recent 12-month period. In the medical supply chain, one disruption can have immediate consequences for patient care and public health. That’s why Cencora is continually expanding our capabilities and building a more resilient pharmaceutical supply chain — so we can overcome disruptions before they impact patients. Here’s how: https://bit.ly/4pX6b8A
-
"Just a few years ago, only about 37% of products required cold chain logistics. Today, and into the future, that number is well over half of products." In a video interview with OncoDaily, Cencora's SVP and President of Specialty Distribution and Solutions, Lisa Thompson Smith spoke about the largely unseen, yet critical infrastructure behind cancer innovation. As the pipeline of innovative therapies grows more complex specialty distribution must evolve to keep pace. From cold-chain logistics and reimbursement complexity to the role of AI in streamlining operations and coordinating care, Lisa examines what it takes to enable community oncologists to deliver the latest the latest therapies to patients and reduce disparities in cancer care. Watch Lisa's interview: https://bit.ly/4yRfMSp
-
-
Sarah just picked up her prescription to help manage her hypertension. But her healthcare journey didn’t begin at the pharmacy counter — it started long before that moment. From clinical development to commercialization, logistics, and patient support, Cencora plays a role at every step to help medicines make their way from the lab to the people who need them most. Retrace Sarah’s journey in reverse and see how each step connects: https://bit.ly/4i4Cyyd
-